460 related articles for article (PubMed ID: 37453022)
1. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
Guo Z; Ashrafizadeh M; Zhang W; Zou R; Sethi G; Zhang X
Cancer Metastasis Rev; 2024 Mar; 43(1):29-53. PubMed ID: 37453022
[TBL] [Abstract][Full Text] [Related]
2. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
[TBL] [Abstract][Full Text] [Related]
3. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
Xu J; Liu S; Yang X; Cao S; Zhou Y
Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
[TBL] [Abstract][Full Text] [Related]
4. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
[TBL] [Abstract][Full Text] [Related]
5. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance.
Palamaris K; Felekouras E; Sakellariou S
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771695
[TBL] [Abstract][Full Text] [Related]
7. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cell in the progression and therapy of pancreatic cancer.
Xu L
Front Biosci (Landmark Ed); 2013 Jun; 18(3):795-802. PubMed ID: 23747847
[TBL] [Abstract][Full Text] [Related]
9. Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition.
Song W; Mazzieri R; Yang T; Gobe GC
Front Immunol; 2017; 8():1106. PubMed ID: 28955335
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.
Wang S; Li Y; Xing C; Ding C; Zhang H; Chen L; You L; Dai M; Zhao Y
Am J Cancer Res; 2020; 10(7):1937-1953. PubMed ID: 32774994
[TBL] [Abstract][Full Text] [Related]
11. STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Sadrkhanloo M; Entezari M; Orouei S; Ghollasi M; Fathi N; Rezaei S; Hejazi ES; Kakavand A; Saebfar H; Hashemi M; Goharrizi MASB; Salimimoghadam S; Rashidi M; Taheriazam A; Samarghandian S
Pharmacol Res; 2022 Aug; 182():106311. PubMed ID: 35716914
[TBL] [Abstract][Full Text] [Related]
12. The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance.
Gu J; Zhang J; Xia R; Wang X; Yang J; Xie F; Zhou Q; Li J; Zhang T; Chen Q; Fan Y; Guo S; Wang H
Drug Resist Updat; 2024 Mar; 73():101027. PubMed ID: 38290407
[TBL] [Abstract][Full Text] [Related]
13. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3.
Wan X; Guo D; Zhu Q; Qu R
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G309-G322. PubMed ID: 32463333
[TBL] [Abstract][Full Text] [Related]
14. CPA4 Promotes EMT in Pancreatic Cancer via Stimulating PI3K-AKT-mTOR Signaling.
Shao Q; Zhang Z; Cao R; Zang H; Pei W; Sun T
Onco Targets Ther; 2020; 13():8567-8580. PubMed ID: 32922037
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of MSMO1 promotes the development and progression of pancreatic cancer.
Cao R; Zhang Z; Tian C; Sheng W; Dong Q; Dong M
J Cancer; 2022; 13(10):3013-3021. PubMed ID: 36046654
[No Abstract] [Full Text] [Related]
16. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
17. EMT and Treatment Resistance in Pancreatic Cancer.
Gaianigo N; Melisi D; Carbone C
Cancers (Basel); 2017 Sep; 9(9):. PubMed ID: 28895920
[TBL] [Abstract][Full Text] [Related]
18. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
Zhang Z; Xu Y
Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner.
Li H; Peng C; Zhu C; Nie S; Qian X; Shi Z; Shi M; Liang Y; Ding X; Zhang S; Zhang B; Li X; Xu G; Lv Y; Wang L; Friess H; Kong B; Zou X; Shen S
Clin Epigenetics; 2021 Jan; 13(1):18. PubMed ID: 33499904
[TBL] [Abstract][Full Text] [Related]
20. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]